Wentao Wang

450 citations
21 papers · 328 indexed · h-index 11
Topics
Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Liver Disease Diagnosis and Treatment (5 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)
Partner nations
ChinaUnited States

In The Last Decade

Wentao Wang

20 papers receiving 325 citations

Peers

Wentao Wang
Comparison fields: 5 of 52
  • Hepatology 167
  • Epidemiology 86
  • Oncology 83
  • Cancer Research 78
  • Surgery 77
Replace Mounes Aliyari Ghasebeh with:
Mounes Aliyari Ghasebeh United States
Can Gan China
Tetsu Tomonari Japan
Hidesuke Yanagida Japan
Mina Hamano Japan
Gui‐Sheng Xie China
Roman Liebe Germany
Ainhoa Lapitz Spain
Hong-Chuan Zhao China
Wentao Wang relative to Mounes Aliyari Ghasebeh United States Mounes Aliyari Ghasebeh's profile →
Citations per field
00.5×2.6×
Mounes Aliyari Ghasebeh · 1×
Citations per year

Countries citing papers authored by Wentao Wang

Since Specialization
Citations

This map shows the geographic impact of Wentao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentao Wang more than expected).

Fields of papers citing papers by Wentao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wentao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentao Wang. The network helps show where Wentao Wang may publish in the future.

Co-authorship network of co-authors of Wentao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wentao Wang. A scholar is included among the top collaborators of Wentao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wentao Wang. Wentao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 10
4 53
5 4
6 24
7 0
8 16
9 6
10 9
11
[Interference of Lumican Regulates the Invasion and Migration of Liver Cancer Cells].
6
12 31
13 9
14 42
15 13
16 20
17 12
18 30
19 27
20 7

About Wentao Wang

Wentao Wang is a scholar working on Hepatology, Immunology and Allergy and Oncology, having authored 21 papers that have together received 328 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Hepatology (167 citations), Cancer Research (78 citations) and Oncology (83 citations). Wentao Wang has collaborated with scholars based in China and United States. Frequent co-authors include Mingqing Xu, Lvnan Yan, Bo Li, Jiayin Yang, Tianfu Wen, Tianfu Wen, Lünan Yan, Peng Xiu, Honglong Wei and Jie Li. Their work appears in journals such as PLoS ONE, Scientific Reports and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026